Effectiveness and Toxicity Burden of Pembrolizumab in Combination With Neoadjuvant Chemotherapy for Stage II/III Triple Negative Breast Cancer: A Real-World Analysis From Alberta, Canada
Year: 2026
Type: article
Study design: Observational Study
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Keywords: pembrolizumab, triple-negative breast cancer, neoadjuvant chemotherapy, carboplatin, KEYNOTE-522, pathological complete response, breast-conserving surgery, axillary lymph node dissection, treatment toxicity, real-world effectiveness, immune checkpoint inhibitors, adjuvant therapy, Alberta
Open Access status: closed
OpenAlex ID: W7225880102
